These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15380692)

  • 1. Molecular introduction to head and neck cancer (HNSCC) carcinogenesis.
    Chin D; Boyle GM; Theile DR; Parsons PG; Coman WB
    Br J Plast Surg; 2004 Oct; 57(7):595-602. PubMed ID: 15380692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes related to head and neck cancer.
    Issing WJ; Wustrow TP; Heppt WJ
    Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
    Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
    Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck cancer: past, present and future.
    Chin D; Boyle GM; Porceddu S; Theile DR; Parsons PG; Coman WB
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1111-8. PubMed ID: 16831082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
    Almadori G; Bussu F; Paludetti G
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of head and neck squamous cell carcinoma.
    Hardisson D
    Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):502-8. PubMed ID: 12736744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
    Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
    J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
    Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
    J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models for human head and neck squamous cell carcinomas.
    Lu SL; Herrington H; Wang XJ
    Head Neck; 2006 Oct; 28(10):945-54. PubMed ID: 16721744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
    Talar-Wojnarowska R; Malecka-Panas E
    Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells in head and neck squamous cell cancer.
    Prince ME; Ailles LE
    J Clin Oncol; 2008 Jun; 26(17):2871-5. PubMed ID: 18539966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
    Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
    Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oncogenes and oncosuppressor role in head and neck carcinomas].
    Pastore A; Pelucchi S; Mastrandrea M
    Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):31-8. PubMed ID: 9036738
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
    Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
    Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.